Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

Pasoon Hellamand, Marleen Van De Sande, Lykke Midtbøll Ørnbjerg, Thomas Klausch, Michael T. Nurmohamed, Ronald F. Van Vollenhoven, Dan Nordström, Anna Mari Hokkanen, Maria Jose Santos, Elsa Vieira-Sousa, Anne G. Loft, Bente Glintborg, Merete Lund Hetland, Ulf Lindström, Johan K. Wallman, Brigitte Michelsen, Eirik Klami Kristianslund, Adrian Ciurea, Michael S. Nissen, Catalin CodreanuCorina Mogosan, Gary J. Macfarlane, Ovidiu Rotariu, Ziga Rotar, Matija Tomšič, Isabel Castrejon, Lucia Otero-Varela, Bjorn Gudbjornsson, Arni Jon Geirsson, Ji Vencovský, Karel Pavelka, Semih Gulle, Berrin Zengin, Florenzo Iannone, Rosario Foti, Mikkel Ostergaard, Irene Van Der Horst-Bruinsma*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network'. Together they form a unique fingerprint.

Medicine & Life Sciences